Paper28233992
Are Dopamine Oxidation Metabolites Involved in the Loss of Dopaminergic Neurons in the Nigrostriatal System in Parkinson's Disease?
Herrera A and 3 others. ACS Chem Neurosci, 2017. Cited by 99 papers, by iCite.
Cite this record
ConductScience Library. Are Dopamine Oxidation Metabolites Involved in the Loss of Dopaminergic Neurons in the Nigrostriatal System in Parkinson's Disease? Papers, record 28233992. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28233992
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Are Dopamine Oxidation Metabolites Involved in the Loss of Dopaminergic Neurons in the Nigrostriatal System in Parkinson's Disease?
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Dopamine | Major topic |
| Dopaminergic Neurons | Major topic |
| Nerve Degeneration | Major topic |
| Parkinson Disease | Major topic |
| Pars Compacta | Major topic |
| Animals | |
| Humans | |
| Melanins | |
| Oxidation-Reduction |
Source PubMed
Cited by62
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 99 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42459575 | The conundrum of alpha-synuclein antibody failures in Parkinson's disease: a narrative review of mechanisms and alternative metabolic hypotheses. | Ther Adv Neurol Disord | 2026 | https://conductscience.org/library/papers/42459575 | PubMed |
| 41463060 | The Enigma of Neuromelanin: How Animal Models Can Help Researchers to Understand the Link Between Pigments and Neurodegeneration. | Biomedicines | 2025 | https://conductscience.org/library/papers/41463060 | PubMed |
| 39738834 | Trace amine-associated receptor 1 (TAAR1): an emerging therapeutic target for neurodegenerative, neurodevelopmental, and neurotraumatic disorders. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | https://conductscience.org/library/papers/39738834 | PubMed |
| 38927076 | Targets to Search for New Pharmacological Treatment in Idiopathic Parkinson's Disease According to the Single-Neuron Degeneration Model. | Biomolecules | 2024 | https://conductscience.org/library/papers/38927076 | PubMed |
| 38254673 | Advancements in Genetic and Biochemical Insights: Unraveling the Etiopathogenesis of Neurodegeneration in Parkinson's Disease. | Biomolecules | 2024 | https://conductscience.org/library/papers/38254673 | PubMed |
| 38196001 | Toxic interactions between dopamine, α-synuclein, monoamine oxidase, and genes in mitochondria of Parkinson's disease. | J Neural Transm (Vienna) | 2024 | https://conductscience.org/library/papers/38196001 | PubMed |
| 38002094 | On the Role of Iron in Idiopathic Parkinson's Disease. | Biomedicines | 2023 | https://conductscience.org/library/papers/38002094 | PubMed |
| 37759540 | Biochemical and Molecular Pathways in Neurodegenerative Diseases: An Integrated View. | Cells | 2023 | https://conductscience.org/library/papers/37759540 | PubMed |
| 37721280 | Single-neuron neurodegeneration as a degenerative model for Parkinson's disease. | Neural Regen Res | 2024 | https://conductscience.org/library/papers/37721280 | PubMed |
| 37569897 | Dihydroxyphenylacetaldehyde Lowering Treatment Improves Locomotor and Neurochemical Abnormalities in the Rat Rotenone Model: Relevance to the Catecholaldehyde Hypothesis for the Pathogenesis of Parkinson's Disease. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37569897 | PubMed |
| 37461364 | Therapeutic Potential of Myricetin in the Treatment of Neurological, Neuropsychiatric, and Neurodegenerative Disorders. | CNS Neurol Disord Drug Targets | 2024 | https://conductscience.org/library/papers/37461364 | PubMed |
| 37063521 | The assessment of executive functions to test the integrity of the nigrostriatal network: A pilot study. | Front Psychol | 2023 | https://conductscience.org/library/papers/37063521 | PubMed |
| 36624932 | In vivo overexpression of synaptogyrin-3 promotes striatal synaptic dopamine uptake in LRRK2R1441G mutant mouse model of Parkinson's disease. | Brain Behav | 2023 | https://conductscience.org/library/papers/36624932 | PubMed |
| 36614266 | Chaperone-Dependent Mechanisms as a Pharmacological Target for Neuroprotection. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36614266 | PubMed |
| 36527527 | Iron and copper ions accelerate and modify dopamine oxidation to eumelanin: implications for neuromelanin genesis. | J Neural Transm (Vienna) | 2023 | https://conductscience.org/library/papers/36527527 | PubMed |
| 36142637 | Role of the Cysteine in R3 Tau Peptide in Copper Binding and Reactivity. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36142637 | PubMed |
| 36105302 | The Anti-Inflammatory Effect of Preventive Intervention with Ketogenic Diet Mediated by the Histone Acetylation of mGluR5 Promotor Region in Rat Parkinson's Disease Model: A Dual-Tracer PET Study. | Parkinsons Dis | 2022 | https://conductscience.org/library/papers/36105302 | PubMed |
| 35664430 | Inhibition of miR-421 Preserves Mitochondrial Function and Protects against Parkinson's Disease Pathogenesis via Pink1/Parkin-Dependent Mitophagy. | Dis Markers | 2022 | https://conductscience.org/library/papers/35664430 | PubMed |
| 35204179 | Neuroprotection against Aminochrome Neurotoxicity: Glutathione Transferase M2-2 and DT-Diaphorase. | Antioxidants (Basel) | 2022 | https://conductscience.org/library/papers/35204179 | PubMed |
| 35142659 | Astrocytes protect dopaminergic neurons against aminochrome neurotoxicity. | Neural Regen Res | 2022 | https://conductscience.org/library/papers/35142659 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| NQO1 | 1728 | PubTator's text mining | https://conductscience.org/library/genes/1728 | NCBI Gene |
| SNCA | 6622 | PubTator's text mining | https://conductscience.org/library/genes/6622 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28233992
GET https://conductscience.org/api/papers/v1/28233992/cited_by?page=2